1,904 top medical experts on Myocardial Infarction across 69 countries and 43 U.S. states, including 1,784 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.
- Myocardial Infarction: necrosis of the myocardium caused by an obstruction of the blood supply to the heart (coronary circulation).
- Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
- Guideline Central: American Medical Association (1, 2, 3, 4, 5)
- UK NICE Guidelines: Myocardial infarction: cardiac rehabilitation and prevention of further cardiovascular disease , Additional
- PubMed Practice Guideline
- U.S. National Guideline Center (archived)
- Broader Categories (#Experts): Infarction (3,955), Myocardial Ischemia (4,027) and Narrower Categories: Anterior Wall Myocardial Infarction (2,700), Cardiogenic Shock (3,822), Inferior Wall Myocardial Infarction (1,208), MINOCA (107), Non-ST Elevated Myocardial Infarction (1,974), ST Elevation Myocardial Infarction (3,610).
- Clinical Trials : at least 2,337 including 95 Active, 1,178 Completed, 330 Recruiting
- Morrow, David A Cardiovascular DiseaseTIMI Study Group, Cardiovascular Division, Brigham and Womens Hospital, Harvard Medical School, Boston, Massachusetts. Top HospitalDisclosed payments from biomedical company (ROCHE DIAGNOSTICS INTERNATIONAL LTD) in 2021 for $3,500Subjects: Acute Coronary Syndrome; Platelet Aggregation Inhibitors; Pyridines; Lactones; Percutaneous Coronary InterventionCategories: Therapeutic Use; Blood; Drug Therapy; Diagnosis; Therapy; Epidemiology
- Jaffe, Allan S Cardiovascular DiseaseDepartment of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA. Top HospitalDisclosed payments in 2021 from 8 biomedical companies, totalling $10,482.5, including $7,625 from Siemens Medical Solutions USA, Inc.Subjects: Troponin T; Troponin I; Troponin; Acute Coronary Syndrome; BiomarkersCategories: Blood; Diagnosis; Metabolism; Therapy; Methods; Analysis
- Krumholz, Harlan M Cardiovascular DiseaseRobert Wood Johnson Foundation Clinical Scholars Program, Yale School of Medicine, New Haven, Connecticut, United States.Subjects: Heart Failure; Hospitalization; Patient Readmission; Pneumonia; MedicareCategories: Statistics & Numerical Data; Mortality; Therapy; Epidemiology; Trends; Economics
- White, Harvey DGreen Lane Cardiovascular Service Auckland City Hospital Auckland New Zealand.Subjects: Acute Coronary Syndrome; Electrocardiography; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Adenosine MonophosphateCategories: Therapeutic Use; Drug Therapy; Therapy; Diagnosis; Mortality; Analogs & Derivatives
- Hamm, Christian WUniversity of Giessen and Kerckhoff Heartand Thorax Center, University of Giessen, Bad Nauheim, Germany.Subjects: Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Angioplasty, Balloon, Coronary; Acute Coronary Syndrome; Purinergic P2Y Receptor AntagonistsCategories: Therapy; Therapeutic Use; Blood; Analogs & Derivatives; Methods; Administration & Dosage
- Alpert, Joseph S Cardiovascular DiseaseCollege of Medicine, University of Arizona, Tucson; Editor in Chief, The American Journal of Medicine. Electronic address: . Top HospitalSubjects: Cardiology; Troponin; Acute Coronary Syndrome; Myocardial Ischemia; MyocardiumCategories: Diagnosis; Blood; Prevention & Control; Pathology; Standards; Statistics & Numerical Data
- Chaitman, Bernard A Cardiovascular DiseaseDepartment of Cardiology, Saint Louis University School of Medicine, St. Louis, Missouri.Disclosed payments in 2021 from 16 biomedical companies, totalling $20,042.26, including $12,208.75 from Daiichi Sankyo Inc.Subjects: Cardiology; Electrocardiography; Coronary Artery Disease; Percutaneous Coronary Intervention; Acute Coronary SyndromeCategories: Diagnosis; Statistics & Numerical Data; Blood; Methods; Mortality; Diagnostic Imaging
- Bhatt, Deepak L Interventional CardiologyHarvard Medical School, Brigham and Womens Hospital Heart & Vascular Center, Boston, Massachusetts, USA. Top HospitalMedical school: Js Weill Medical College, Cornell University (MD, 1993)Medicare AcceptedDisclosed payments in 2021 from 32 biomedical companies, totalling $169,114.48, including $51,540 from PFIZER INC.Subjects: Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Stroke; Coronary Artery Disease; Purinergic P2Y Receptor AntagonistsCategories: Therapeutic Use; Therapy; Drug Therapy; Epidemiology; Prevention & Control; Mortality
- Bax, Jeroen JDepartment of Cardiology, Leiden University Medical Center, Leiden, The Netherlands; Heart Center, Turku University Hospital and University of Turku, Turku, Finland.Subjects: Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling; Angioplasty, Balloon, Coronary; ElectrocardiographyCategories: Diagnostic Imaging; Physiopathology; Methods; Pathology; Therapy; Physiology
- Libby, Peter Cardiovascular DiseaseDivision of Cardiovascular Medicine, Brigham and Womens Hospital, Harvard Medical School, Boston, Massachusetts. Top HospitalRelevant US NIH Grant Funding: $1,683,824 over the last 5 yearsMedical school: University of California, San Diego School of Medicine (MD, 1973)Medicare AcceptedSubjects: Monocytes; Atherosclerosis; Macrophages; Ventricular Remodeling; Anti-Inflammatory AgentsCategories: Metabolism; Physiology; Therapeutic Use; Drug Therapy; Genetics; Physiopathology
- Stone, Gregg W Cardiovascular DiseaseZena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York, USA. Top HospitalRelevant US NIH Grant Funding: $449,530 over the last 5 yearsDisclosed payments in 2021 from 41 biomedical companies, totalling $233,124.64, including $66,000 from HeartFlow, Inc.Subjects: Percutaneous Coronary Intervention; Angioplasty, Balloon, Coronary; Drug-Eluting Stents; Stents; Coronary Artery DiseaseCategories: Therapy; Therapeutic Use; Administration & Dosage; Adverse Effects; Methods; Surgery
- Granger, Christopher B Family MedicineDuke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA . Top HospitalMedical school: Louisiana State University School of Medicine In New Orleans (MD, 2002)Medicare AcceptedSubjects: Percutaneous Coronary Intervention; Angioplasty, Balloon, Coronary; Electrocardiography; Myocardial Reperfusion; Single-Chain AntibodiesCategories: Therapy; Therapeutic Use; Methods; Statistics & Numerical Data; Mortality; Drug Therapy
- Steg, Ph GabrielUniversité de Paris, Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, French Alliance for Cardiovascular Trials, and INSERM U1148, Paris, France.Subjects: Platelet Aggregation Inhibitors; Percutaneous Coronary Intervention; Stroke; Acute Coronary Syndrome; AdenosineCategories: Therapeutic Use; Drug Therapy; Analogs & Derivatives; Epidemiology; Prevention & Control; Administration & Dosage
- Windecker, StephanDepartment of Cardiology, Inselspital, University of Bern, Bern, Switzerland.Subjects: Percutaneous Coronary Intervention; Drug-Eluting Stents; Coronary Artery Disease; Sirolimus; Platelet Aggregation InhibitorsCategories: Therapy; Therapeutic Use; Methods; Surgery; Adverse Effects; Administration & Dosage
- Wijns, WilliamThe Lambe Institute for Translational Medicine and Curam Galway Ireland.Subjects: Percutaneous Coronary Intervention; Drug-Eluting Stents; Angioplasty, Balloon, Coronary; Coronary Artery Disease; Platelet Aggregation InhibitorsCategories: Therapy; Surgery; Administration & Dosage; Analogs & Derivatives; Standards; Adverse Effects
- Peterson, Eric D Cardiovascular DiseaseUniversity of Texas Southwestern Medical Center, Dallas, TX, USA. Top HospitalDisclosed payments in 2021 from 17 biomedical companies, totalling $29,475.73, including $16,220.73 from Bayer HealthCare Pharmaceuticals Inc.Subjects: Registries; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Guideline AdherenceCategories: Therapy; Statistics & Numerical Data; Therapeutic Use; Drug Therapy; Epidemiology; Methods
- Januzzi, James L Cardiovascular DiseaseDivision of Cardiology, Massachusetts General Hospital, Boston, Massachusetts, USA; Baim Institute for Clinical Research, Boston, Massachusetts, USA. Electronic address: https://twitter.com/JJheart_doc. Top HospitalMedical school: New York Medical College (MD, 1994)Medicare AcceptedDisclosed payments in 2021 from 53 biomedical companies, totalling $125,554, including $33,800 from ROCHE DIAGNOSTICS INTERNATIONAL LTDSubjects: Troponin T; Acute Coronary Syndrome; Heart Failure; Patient Readmission; TroponinCategories: Blood; Diagnosis; Epidemiology; Metabolism; Complications; Methods
- Ridker, Paul M Cardiovascular DiseaseDivision of Preventive Medicine, Brigham and Womens Hospital, Boston, Massachusetts, United States of America. Top HospitalRelevant US NIH Grant Funding: $17,328,279 over the last 5 yearsMedical school: Harvard Medical School (MD, 1986)Medicare AcceptedDisclosed payments in 2021 from 21 biomedical companies, totalling $48,864, including $19,500 from Novo Nordisk ASSubjects: Stroke; Antibodies, Monoclonal; Atherosclerosis; C-Reactive Protein; Cardiovascular DiseasesCategories: Genetics; Therapeutic Use; Epidemiology; Prevention & Control; Drug Therapy; Administration & Dosage
These expert listings are
for individual use without a fee. Biotechs,
Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and
other organizations may use this only for quick evaluations (no downloads, screen scraping or using the data) to identify the top medical experts for recruiting, advisory panels, boards,
and consulting. Please contact
us for licensing, customized queries, feedback and questions.
Note:
- Only the top 20 experts are shown. You may filter your results or use the geolocation tabs. Contact us to purchase the entire list.